Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03487224 · ClinicalTrials.gov registry record
Neural Mechanisms of Decision Making in Hoarding Disorder
A clinical trial of Hoarding Disorder, sponsored by Stanford University.
- Active
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT03487224: Active study of Hoarding Disorder, sponsored by Stanford University.
NCT03487224 is a study of Hoarding Disorder that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 25 participants, below the 34-participant average among 4 other Hoarding Disorder trials with a reported enrollment target (26% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03487224, a study of Hoarding Disorder, is active but no longer recruiting, sponsored by Stanford University.
- ACTIVE NOT RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand the neural mechanisms of decision making in hoarding disorder.
Primary Outcome
BOLD signal derived from fMRI
Conditions Studied
Interventions
- DEVICE MRI with fMRI frequency
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-07-08 |
| Est. Completion | 2026-05-30 |
What the registry record for NCT03487224 still lists
NCT03487224 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 34-participant average among 4 other Hoarding Disorder trials with a reported enrollment target (26% lower).
The record links to 1 condition, with Hoarding Disorder appearing as the primary indexed condition, and to 1 intervention - of which MRI with fMRI frequency is the first listed.
NCT03487224 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03487224 about?
NCT03487224 is a clinical study titled "Neural Mechanisms of Decision Making in Hoarding Disorder". The purpose of this study is to understand the neural mechanisms of decision making in hoarding disorder.
What is the current status of trial NCT03487224?
This trial is currently active not recruiting. The enrollment target is 25 participants. The study started on 2018-07-08. Estimated completion is 2026-05-30.
What conditions does trial NCT03487224 study?
This clinical trial studies the following conditions: Hoarding Disorder.
What interventions are being tested in trial NCT03487224?
The interventions under investigation include: MRI with fMRI frequency (DEVICE).
Who is sponsoring clinical trial NCT03487224?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03487224 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hoarding Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Motivational Interviewing to Enhance Behavioral Change in Older Adults with Hoarding Disorder
RECRUITING · NA
-
Rapid Non-Invasive Brain Stimulation for Hoarding Disorder
RECRUITING · NA
-
Self-Help Group for the Treatment of Hoarding Disorder
ACTIVE NOT RECRUITING · NA
-
Enhancing Attention in Adults With Compulsive Hoarding
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI